An Open-Label, Multicenter, Single-Arm, Phase-2 Study of Single-Agent Mosunetuzumab (BTCT4465A, RO7030816) for the Treatment of Patients with Newly Diagnosed Follicular Lymphoma in Need of Systemic Therapy. Read more
Role of Donor Cell Chimerism in Predicting Relapse Post-Transplant in Patients with Hematologic Malignancies Read more
Incidence of Engraftment Syndrome in Classical Hodgkin Lymphoma after Checkpoint Inhibitors: A Retrospective Analysis Read more
Transcriptional Profiles of CD19 Chimeric Antigen Receptor (CAR) T-cells that Induce Durable Remission in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Read more
A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia Read more
“Clinico-genomic Predictors of Outcomes Among Patients with HIV or Paraneoplastic Syndromes and Cancer” Read more
